EBITDA of EBOS Group FY 2016-2022

Published by Statista Research Department, Mar 21, 2023
In financial year 2022, EBOS Group's Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) totaled 405.8 million Australian dollars. EBOS Group is an Australasian marketer, wholesaler and distributer of healthcare, medical, and pharmaceutical products and is publicly listed on the ASX.

EBITDA of EBOS Group in financial year 2016 to 2022 (in million Australian dollars)

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

August 2022

Region

Australia

Survey time period

financial year 2016 to 2022

Supplementary notes

EBITDA: Earnings Before Interest, Taxes, Depreciation and Amortization

Australia's financial year runs from July 1 to June 30; for example, financial year 2017 starts on July 1, 2016 and ends on June 30, 2017.

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$149 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Pharmaceutical industry in Australia "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in Australia

Overview

6

Prescription medication

6

Major Pharmaceuticals

5

Pharmaceutical retailers

7

Trends

7

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in AustraliaGlobal pharmaceutical industryDrug Store/Pharmacy Market in the U.S.Top pharmaceutical drugsPharmaceutical research and development (R&D)
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu